The Journal of clinical endocrinology and metabolism · 2025
Association of Maternal Thyroglobulin Antibody With Preterm Birth in Euthyroid Women.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Shuai, Huang Zixuan, Zhang Yong, Li Yanan, Zhou Yulai, Guan Haixia, Fan Jianxia
Аннотация
CONTEXT: While the association between maternal thyroid peroxidase antibody (TPOAb) positivity and preterm birth (PTB) risk has been established, the association between thyroglobulin antibody (TgAb) and PTB remains unclear.
OBJECTIVE: This study aimed to explore the association between TgAb and PTB risk in euthyroid women.
METHODS: This single-center, prospective cohort study enrolled euthyroid women in the first trimester. Data on serum concentrations of thyrotropin (TSH), free thyroxine (FT4), TgAb, and TPOAb were collected. Participants were categorized into 2 groups (TgAb-negative and TgAb-positive). PTB was subtyped into spontaneous PTB (S-PTB) and medically induced PTB (MI-PTB); and into early PTB (E-PTB) and late PTB (L-PTB). Logistic regression models examined the associations between TgAb and PTB and its subtypes, with stratification by first-trimester TSH levels (0.1-2.5 mIU/L, 2.5-4.0 mIU/L).
RESULTS: This study comprised 58 247 euthyroid pregnant women. Adjusting for confounders, TgAb positivity was associated with a 16% increased risk of PTB (adjusted odds ratio (aOR) 1.16, 95% CI, 1.03-1.29; P = .01) compared to the TgAb-negative group. Specifically, TgAb positivity showed a higher risk of S-PTB and L-PTB, aOR 1.22 (95% CI, 1.06-1.39) and aOR 1.17 (95% CI, 1.04-1.32), respectively. Consistent results were observed when analyzing TgAb concentration as a continuous variable. TSH stratification analysis revealed that these associations were statistically significant only among women with TSH levels between 0.1 and 2.5 mIU/L.
CONCLUSION: In euthyroid women, TgAb positivity was associated with a higher risk of PTB that mainly manifested as S-PTB and L-PTB. However, the clinical significance of these findings is limited.
OBJECTIVE: This study aimed to explore the association between TgAb and PTB risk in euthyroid women.
METHODS: This single-center, prospective cohort study enrolled euthyroid women in the first trimester. Data on serum concentrations of thyrotropin (TSH), free thyroxine (FT4), TgAb, and TPOAb were collected. Participants were categorized into 2 groups (TgAb-negative and TgAb-positive). PTB was subtyped into spontaneous PTB (S-PTB) and medically induced PTB (MI-PTB); and into early PTB (E-PTB) and late PTB (L-PTB). Logistic regression models examined the associations between TgAb and PTB and its subtypes, with stratification by first-trimester TSH levels (0.1-2.5 mIU/L, 2.5-4.0 mIU/L).
RESULTS: This study comprised 58 247 euthyroid pregnant women. Adjusting for confounders, TgAb positivity was associated with a 16% increased risk of PTB (adjusted odds ratio (aOR) 1.16, 95% CI, 1.03-1.29; P = .01) compared to the TgAb-negative group. Specifically, TgAb positivity showed a higher risk of S-PTB and L-PTB, aOR 1.22 (95% CI, 1.06-1.39) and aOR 1.17 (95% CI, 1.04-1.32), respectively. Consistent results were observed when analyzing TgAb concentration as a continuous variable. TSH stratification analysis revealed that these associations were statistically significant only among women with TSH levels between 0.1 and 2.5 mIU/L.
CONCLUSION: In euthyroid women, TgAb positivity was associated with a higher risk of PTB that mainly manifested as S-PTB and L-PTB. However, the clinical significance of these findings is limited.